AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02503241 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PEEP DECREMENTAL
Description: Lung recruitment maneuver (LRM) is a transitory and controlled increase in airway pressure to open collapsed alveoli. LRM is the first step of the PEEP DECREMENTAL method. After LRM, PEEP is systematically decreased, in small decrements, until the best respiratory system mechanics is identified.
Study NCT02470780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin
Description: Rifaximin is an antibiotic used to treat SIBO. It is a 7-day course of treatment followed by three or six months of follow-up. This is a placebo-controlled study designed so that all participants will receive the active drug at least once during the study.
Study NCT02470780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo matching Rifaximin treatment.
Study NCT02159040 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azacitidine
Description: SC or IV AZA at 75mg/m2 7 days/28 day cycle
Study NCT02159040 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine plus Deferasirox
Description: SC or IV AZA at 75mg/m2 7 days/28 day cycle DFX 10mg/kg/day
Study NCT01624077 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Regulatory T cells
Description: Tregs will inject after liver transplantation
Study NCT00819702 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Model Care
Description: The Model Care provided training to pediatric health care providers to assess parental psychosocial risk factors to child maltreatment.
Study NCT03614260 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paradise Renal Denervation System
Description: Following renal angiogram according to standard procedures, subjects remain blinded and are immediately treated with the renal denervation procedure after randomization.
Study NCT03614260 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Renal Angiogram
Description: Following renal angiogram to standard procedures, subjects remain blinded and renal angiogram is considered the sham procedure.
Study NCT02028325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorescein Sodium
Description: All patients enrolled in the study will prepare for surgery as per standard neurosurgical indications, procedures and institution protocols. At the time of the anesthesia induction, with the patient under general anesthesia, Fluorescein Sodium 10% (100mg/1mL) at a dose of 3-20 mg/kg will be administered intravenously (the optimal dosage will be determined within the study as the most minimal dose for adequate visualization will be used). For vascular lesions, fluorescein sodium 10% (100mg/1mL) will be injected and used to assess its application after the conventional methods have confirmed the exclusion of the aneurysm. No patient's care will be affected by the results of the Fluorescein angiography.
Study NCT01871337 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paula method
Description: The Paula method will be taught to the participants by several registered Paula instructors. Subjects allocated to this intervention will receive one 45-minute group session per week for 12 weeks (with up to 30 minutes for personal questions regarding the exercises). This length of time is crucial because it has been demonstrated that it take three months for women to adequately learn the exercises in order for them to practice independently at home. Participants will be encouraged to practice daily for 15 minutes and report their at- home training.
Study NCT04653233 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D Systems Touch Haptic Simulator
Description: This simulator is computer-aided and allows us to see this application on the computer screen while practicing with a haptic arm. It gives real-like feedback in hand manipulations. The simulator has a choice of 45 minutes of full instruction, 5 minutes of haptic arm only, or the option.
Study NCT05715749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: In-home body weight support harness system
Description: A portable, adjustable body weight support harness system that occupies roughly 9 feet x 9 feet space in the home. The system allows 360 degrees of mobility anywhere within the footprint of the frame. The amount of body weight support is adjustable.
Study NCT03495973 — intervention group
Intervention type: DRUG
Intervention: Ustekinumab
Description: Participants that are initiated on treatment with ustekinumab and are registered in Swibreg will be recruited into the cohort. All aspects of treatment and clinical management of participants will be in accordance with local clinical practice and applicable local regulations, and at the discretion of the participating physician.
Study NCT03362983 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CareHND
Description: Multidisciplinary, integrated, person-centered care at the integrated HND-clinic
Study NCT03392168 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARQ-151 cream 0.5%
Description: 0.5% active concentration
Study NCT03392168 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARQ-151 cream 0.15%
Description: 0.15% active concentration
Study NCT03392168 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ARQ-151 vehicle cream
Description: Vehicle cream
Study NCT04341129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine)
Description: To test the diagnostic effectiveness of an abbreviated MRI to a full MRI in the evaluation of breast lesions using Dotarem
Study NCT03101202 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SSD tube
Description: The SSD tube allows the suction of subglottic secretions that collect above the cuff of the endotracheal tube
Study NCT03128281 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires
Description: Questionnaires completed 30 days before surgery, two (2) hours after surgery, when leaving the post-anesthesia care unit (PACU), and at hospital discharge.~Questionnaires ask about pain level and any drugs taken for it. It should take about 5 minutes to complete.
Study NCT03128281 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires completed 30 days before surgery, two (2) hours after surgery, when leaving the post-anesthesia care unit (PACU), and at hospital discharge.~Questionnaires ask about pain level and any drugs taken for it. It should take about 5 minutes to complete.
Study NCT03128281 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conventional Insufflation System (CIS)
Description: CIS with pressure target of 15±1 mmHg used for pneumoperitoneum during laparoscopic/robotic surgery.
Study NCT03128281 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ConMed AirSeal Insufflation System (AIS) at Low Pressure
Description: AIS with an insufflation pressure target of 9±1 mmHg used for pneumoperitoneum during laparoscopic/robotic surgery.
Study NCT03128281 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ConMed AirSeal Insufflation System (AIS) at Higher Pressure
Description: AIS with an insufflation pressure target of 15±1 mmHg used for pneumoperitoneum during laparoscopic/robotic surgery.
Study NCT02744248 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IOP Injection
Description: IOP Injection 20 mg Fe/ml, intravenous injection
Study NCT02744248 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% normal saline
Description: 0.9% normal saline 10 ml, intravenous injection
Study NCT01724034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abolish Lung Sliding
Description: If there is no lung sliding, the patient will be promptly evaluated for pneumothorax or mainstream intubation.
Study NCT01724034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normal Lung Ultrasound
Description: If the patient fails the spontaneous breathing trial and the lung ultrasound examination is normal - researchers will investigate venous thrombosis (deep vein thrombosis and/or pulmonary embolism) and rule out reversible airway obstruction. If the patient has the previous diagnosis of COPD, non invasive mechanical ventilation is indicated for facilitate weaning.
Study NCT01724034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary Interstitial Syndrome
Description: If lung ultrasound shows B pattern - cardiogenic pulmonary edema will be differentiated from Acute Respiratory Distress Syndrome (ARDS). If cardiogenic edema is a possibility, diuretics will be administrated (at least 40 mg of furosemide) or ultrafiltration will be performed. The main target is a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial. Another possibility is to titrate vasodilators (at least a 20% reduction in the systolic blood pressure) before the next spontaneous breathing trial.
Study NCT01724034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Asymmetrical Lung Ultrasound
Description: If lung ultrasound shows asymmetrical findings, the occurence of new or uncontrolled infection (pulmonary or extrapulmonary) will be investigated.
Study NCT01724034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simple Pleural Effusion
Description: If the patient has pleural effusion without ultrasonographic signs of complications (any hyperechoic pattern or complex septated pattern), researchers will administrate diuretics (at least 40 mg of furosemide in 24 hours) or increase ultrafiltration - to achieve a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial. Another possibility is to perform pleural drainage.
Study NCT01724034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Complex Pleural Effusion
Description: If there is pleural effusion with hyperechoic or septated pattern, another image exam will be performed and evaluated by the surgical team.
Study NCT02847390 — intervention group
Intervention type: OTHER
Intervention: Education intervention
Description: The investigators will develop and deliver a diabetes physician and nursing inpatient diabetes superuser educational curriculum focused on delivering safe, evidence-based diabetes care in the hospital setting. The physician educational curriculum will consist of 10 case-based modules taught to internal medicine residents at two academic hospitals and taught to hospitalists at two academic hospitals and one community hospital. The nursing educational curriculum will consistent of 12 case-based modules taught to unit-based nurses at two academic hospitals and one community hospital. These educational interventions will be delivered over a 6-month time frame from August 2016-April 2017.
Study NCT03931759 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic surgery
Description: patients with diabetes mellitus in laparoscopic surgery
Study NCT03610347 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bare metal Stent plus Paclitaxel Balloon
Study NCT03610347 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Drug Eluting Stent
Study NCT02437942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biomechanics led physical therapy rehabilitation
Description: Rehabilitation intervention will consist of movement control (3 days per week), whole body strength and power (2 days per week), linear running mechanics (3 days per week), multi-directional mechanics (3 days per week), conditioning sessions (2 days per week). Rehabilitation will continue until physical therapist deems the athlete ready to return to sport.
Study NCT01543542 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Whole Brain XRT 30Gy/10 fractions with
Description: 30 Gy of whole brain external beam radiation delivered in 10 fractions. Simultaneous in-field boost of brain lesions to 60 Gy.
Study NCT01195623 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: preoperative duplex examination
Study NCT01195623 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative duplex
Study NCT02499523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: THR with conventional technique
Description: THR with conventional technique.
Study NCT03695263 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choice of one of five behavioral interventions
Description: All participants will choose one of the five intervention options.
Study NCT02499523 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: THR with Acetabular Cup Orientation Guides (ACOG)
Description: THR with the ACOG System.
Study NCT04557358 — intervention group
Intervention type: OTHER
Intervention: COVID-19 survey
Description: A questionnaire locally developed to explore access to medical care and to medications, access to communication with their primary rheumatologist, and patients risk perception about COVID-19 disease
Study NCT04557358 — intervention group
Intervention type: OTHER
Intervention: RAPID-3
Description: The instrument measures function, pain, and patient global estimate of status, with correspond to activity disease
Study NCT04557358 — intervention group
Intervention type: OTHER
Intervention: WHOQOL-BREF
Description: The instrument measures the patient´s quality of life (4 dimensions: physics, phycological, social, and environment)
Study NCT04557358 — intervention group
Intervention type: OTHER
Intervention: DASS-21 instrument (depression and anxiety)
Description: The instrument measures the presence of depression and anxiety
Study NCT02830412 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postoperative nausea and vomiting (PONV) reminder
Description: The postoperative nausea and vomiting (PONV) electronic reminder will be programmed to assess the patient risk for PONV according to the risk factors identified by Apfel and Koivuranta. The PONV risk assessment and current guidelines will be displayed electronically for patients randomized to receive the reminder.
Study NCT00101868 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Discharge communication software
Description: Computerized physician order entry software used by discharging physician
Study NCT00101868 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care discharge process
Description: Handwritten
Study NCT01619878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (COA566)
Description: One dispersible tablet taken orally twice a day during 3 days.
Study NCT02155699 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise 1
Description: 65% of VO2max and 2 sessions per week
Study NCT02155699 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise 2
Description: 85% intensity and 3 sessions per peek
Study NCT01167400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cybercycling
Description: exercising on a videogame-enhanced interactive 3D stationary bicycle for 3 months, 3-5x/wk
Study NCT01167400 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional exercise
Description: exercising on a traditional stationary bike for 3 months, 3-5x/wk
Study NCT02619097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegol-sihematide injection
Description: single dose
Study NCT03839394 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone
Description: A series of educational pamphlets on CVD risk reduction plus a telephone-based CVD risk reduction curriculum will be administered by Clinic-Based Case Managers (CCMs). Six modules will be given over 24 weeks in a rotating fashion on topics relevant to CVD risk. Subjects will be given the pamphlets every 2 weeks corresponding with the first time they receive the telephone - based module.
Study NCT03839394 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational pamphlets
Description: A series of 6 handouts will be given to controls once monthly over 6 months on the same topics presented in the telephone modules. Educational packets will be primarily drawn from free printed material available at www.learningaboutdiabetes.org and the American Heart Association website.
Study NCT03839394 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational pamphlets
Description: A series of 6 handouts will be given to controls once monthly over 6 months on the same topics presented in the telephone modules. Educational packets will be primarily drawn from free printed material available at www.learningaboutdiabetes.org and the American Heart Association website.
Study NCT00941304 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone
Description: Single-dose of over-encapsulated oral 5-mg oxycodone capsule
Study NCT00941304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Description: Single-dose of buprenorphine HCl buccal film
Study NCT00941304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Film
Description: Single-dose of placebo buccal film
Study NCT00941304 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Film
Description: Single-dose of placebo buccal film
Study NCT00941304 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Film
Description: Single-dose of placebo buccal film
Study NCT00941304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Capsule
Description: Single-dose of oral placebo capsule
Study NCT00941304 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Capsule
Description: Single-dose of oral placebo capsule
Study NCT05923710 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Primary anterior cruciate ligament repair
Description: Only arthroscopic primary anterior cruciate ligament repair was performed in patients with proximal anterior cruciate ligament tear.
Study NCT05923710 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Primary anterior cruciate ligament repair and lateral extraarticular tenodesis (LET) with iliotibial band
Description: In addition to primary anterior cruciate ligament repair, lateral extraarticular tenodesis was performed using the iliotibial band.
Study NCT00595543 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bromfenac
Description: 1 drop (in the eye) Instill one drop in the affected eye twice daily for three months
Study NCT00595543 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketorolac
Description: 1 drop (in the eye) Instill one drop in the affected eye four times daily for three months
Study NCT00595543 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Description: 1 drop (in the eye) Instill one drop in the affected eye four times daily for three months
Study NCT03293394 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Anodal bilateral motor cortex and cathodal spinal tDCS
Description: 10 sessions of anodal bilateral motor cortex and cathodal spinal transcranial direct current stimulation (5 days/week for 2 weeks)
Study NCT03293394 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham bilateral motor cortex and sham spinal tDCS
Description: 10 sessions of sham bilateral motor cortex and sham spinal transcranial direct current stimulation (5 days/week for 2 weeks)
Study NCT04557358 — intervention group
Intervention type: OTHER
Intervention: IER-R (posttraumatic stress)
Description: The instrument measures the presence of posttraumatic stress
Study NCT02721992 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT02256839 — intervention group
Intervention type: DEVICE
Intervention: CST_001
Study NCT02267070 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Case management and supportive psychotherapy
Description: An individual therapist will provide weekly case management and therapy targeting the individual psychological problems and everyday functioning needs of the patient
Study NCT02267070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Case management and supportive psychotherapy
Description: An individual therapist will provide weekly case management and therapy targeting the individual psychological problems and everyday functioning needs of the patient
Study NCT02267070 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Family psychoeducation
Description: All immediate family members will be invited to family psychoeducation sessions.
Study NCT02267070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family psychoeducation
Description: All immediate family members will be invited to family psychoeducation sessions.
Study NCT02267070 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive training
Description: The Cognitive Training and Exercise intervention involves 24 weeks of systematic computerized cognitive training, 4 hours per week, plus aerobic exercise, four 30 minute sessions per week. The first 12 weeks involves neurocognitive training, using auditory training exercises from Posit Science Brain HQ. The second 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. A weekly one-hour Bridging Skills Group with other members of the treatment condition is designed to aid generalization of training to everyday life situations.
Study NCT02267070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive training
Description: The Cognitive Training and Exercise intervention involves 24 weeks of systematic computerized cognitive training, 4 hours per week, plus aerobic exercise, four 30 minute sessions per week. The first 12 weeks involves neurocognitive training, using auditory training exercises from Posit Science Brain HQ. The second 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. A weekly one-hour Bridging Skills Group with other members of the treatment condition is designed to aid generalization of training to everyday life situations.